A detailed history of Cornerstone Investment Partners, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cornerstone Investment Partners, LLC holds 1,871 shares of CRL stock, worth $372,890. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,871
Previous 1,869 0.11%
Holding current value
$372,890
Previous $386,000 4.66%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $375 - $490
2 Added 0.11%
1,871 $368,000
Q2 2024

Aug 12, 2024

BUY
$206.39 - $268.73 $97,416 - $126,840
472 Added 33.79%
1,869 $386,000
Q1 2024

Apr 29, 2024

BUY
$203.52 - $273.43 $5,088 - $6,835
25 Added 1.82%
1,397 $378,000
Q4 2023

Jan 31, 2024

BUY
$164.52 - $238.84 $225,721 - $327,688
1,372 New
1,372 $324,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cornerstone Investment Partners, LLC Portfolio

Follow Cornerstone Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.